Clover Health Investments SG&A Expense (Quarterly) Analysis

Clover Health Investments Corp (CLOV)

0.82 -0.04 (-5.02%) USD | NASDAQ | May 10, 16:00

0.82 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	103.79M
December 31, 2023	109.93M
September 30, 2023	102.31M
June 30, 2023	104.87M
March 31, 2023	126.62M
December 31, 2022	124.35M
September 30, 2022	117.97M
June 30, 2022	117.53M
March 31, 2022	126.79M

Date	Value
December 31, 2021	114.08M
September 30, 2021	119.21M
June 30, 2021	107.81M
March 31, 2021	104.64M
December 31, 2020	54.95M
September 30, 2020	46.48M
June 30, 2020	40.70M
March 31, 2020	49.97M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

40.70M

Minimum

Jun 2020

126.79M

Maximum

Mar 2022

98.35M

Average

107.81M

Median

Jun 2021

SG&A Expense (Quarterly) Benchmarks